Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublimated mare's milk in NASH
NCT03664596Completed
- Start
- Aug 2018
- Primary completion
- Sep 2020
- Countries
- 1
01
Overview
Randomised, open-label trial in Nonalcoholic steatohepatitis (NASH). Primary endpoints: Change in liver function indicators at 8 weeks and Change in degree of steatosis and fibrosis by fibroelastometry at 8 weeks. Started Aug 2018; status: completed.
02
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT03664596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03664596.